FRUSCIO, ROBERT
 Distribuzione geografica
Continente #
NA - Nord America 16.046
EU - Europa 7.106
AS - Asia 3.383
SA - Sud America 107
OC - Oceania 35
AF - Africa 33
Continente sconosciuto - Info sul continente non disponibili 23
Totale 26.733
Nazione #
US - Stati Uniti d'America 15.765
IT - Italia 1.654
CN - Cina 1.355
IE - Irlanda 1.159
DE - Germania 889
SE - Svezia 874
SG - Singapore 864
RU - Federazione Russa 647
UA - Ucraina 631
HK - Hong Kong 530
GB - Regno Unito 414
CA - Canada 248
FI - Finlandia 200
FR - Francia 150
VN - Vietnam 134
IN - India 129
TR - Turchia 113
AT - Austria 86
DK - Danimarca 79
ID - Indonesia 78
ES - Italia 67
NL - Olanda 65
JP - Giappone 58
BE - Belgio 54
BR - Brasile 43
MX - Messico 29
AU - Australia 28
CH - Svizzera 27
IR - Iran 26
CO - Colombia 24
CZ - Repubblica Ceca 22
SK - Slovacchia (Repubblica Slovacca) 19
PL - Polonia 18
TH - Thailandia 17
EG - Egitto 15
EU - Europa 15
CL - Cile 14
KR - Corea 13
BG - Bulgaria 12
PH - Filippine 12
IL - Israele 11
GR - Grecia 10
PT - Portogallo 9
A2 - ???statistics.table.value.countryCode.A2??? 8
PE - Perù 8
RO - Romania 8
TW - Taiwan 8
VE - Venezuela 8
MY - Malesia 6
AR - Argentina 5
NG - Nigeria 5
NZ - Nuova Zelanda 5
BO - Bolivia 4
LK - Sri Lanka 4
GT - Guatemala 3
HR - Croazia 3
MD - Moldavia 3
PK - Pakistan 3
SA - Arabia Saudita 3
ZA - Sudafrica 3
AZ - Azerbaigian 2
FJ - Figi 2
IQ - Iraq 2
KZ - Kazakistan 2
MW - Malawi 2
MZ - Mozambico 2
RS - Serbia 2
SC - Seychelles 2
SY - Repubblica araba siriana 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
BD - Bangladesh 1
CI - Costa d'Avorio 1
CY - Cipro 1
ET - Etiopia 1
GE - Georgia 1
HN - Honduras 1
KG - Kirghizistan 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
LV - Lettonia 1
MA - Marocco 1
MN - Mongolia 1
MO - Macao, regione amministrativa speciale della Cina 1
NO - Norvegia 1
NP - Nepal 1
SN - Senegal 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 26.733
Città #
Ann Arbor 3.294
Woodbridge 1.570
Fairfield 1.493
Dublin 1.105
Houston 1.061
Chandler 948
Ashburn 851
Wilmington 815
Singapore 722
Jacksonville 685
Seattle 616
Frankfurt am Main 576
Cambridge 518
Hong Kong 503
Dearborn 488
New York 466
Princeton 426
Milan 350
Hangzhou 220
Nanjing 206
Lawrence 191
Altamura 170
Beijing 167
Santa Clara 162
Boardman 155
Shanghai 149
Lachine 112
San Diego 102
Vienna 83
Lissone 81
Nanchang 77
Jakarta 73
Andover 62
Helsinki 62
Ottawa 60
Dong Ket 56
Guangzhou 56
Fremont 52
London 52
Shenyang 52
Rome 47
Hebei 44
Toronto 42
Dallas 39
Brussels 38
Changsha 38
Falls Church 34
Los Angeles 34
Jinan 33
Kunming 33
Norwalk 31
Chicago 29
Jiaxing 28
Tianjin 28
Pune 27
Huizen 25
Redmond 21
Florence 20
Istanbul 19
Lappeenranta 19
Bratislava 18
Hefei 18
Padova 18
Monza 17
Amsterdam 16
Brno 16
Carate Brianza 16
Madrid 15
Mountain View 15
Zhengzhou 15
Edmonton 14
Ningbo 14
Washington 14
Leawood 13
San Mateo 13
Bonndorf 12
Desio 12
São Paulo 12
Taizhou 12
Turin 12
Kilburn 11
Lanzhou 11
Melbourne 11
Adana 10
Kanazawa 10
Tokyo 10
Verona 10
Antalya 9
Brescia 9
Naples 9
Shenzhen 9
Trieste 9
Cairo 8
Chengdu 8
Chongqing 8
Hanoi 8
Kiev 8
Menlo Park 8
Munich 8
Paris 8
Totale 19.990
Nome #
Predicting the risk of malignancy in adnexal masses based on the Simple Rules from the International Ovarian Tumor Analysis group 493
Management and outcome of colorectal cancer during pregnancy: report of 41 cases 408
Oncologic and fertility impact of surgical approach for borderline ovarian tumours treated with fertility sparing surgery 355
Radiomics of the primary tumour as a tool to improve 18F-FDG-PET sensitivity in detecting nodal metastases in endometrial cancer 310
Evaluating the risk of ovarian cancer before surgery using the ADNEX model to differentiate between benign, borderline, early and advanced stage invasive, and secondary metastatic tumours: prospective multicentre diagnostic study 306
Multisite analysis of high-grade serous epithelial ovarian cancers identifies genomic regions of focal and recurrent copy number alteration in 3q26.2 and 8q24.3 288
Ovarian function, fertility, and menopause occurrence after fertility-sparing surgery and chemotherapy for ovarian neoplasms 283
Combining positron emission tomography/computed tomography, radiomics, and sentinel lymph node mapping for nodal staging of endometrial cancer patients 274
Reducing the environmental impact of surgery on a global scale: systematic review and co-prioritization with healthcare workers in 132 countries 266
Role of 18F-fluoro-2-deoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) in malignant ovarian germ cell tumors: a single-center experience with long term follow-up 260
Prevalence of human papillomavirus (HPV) and other sexually transmitted infections (STIS) among italian women referred for a colposcopy 236
Staging of High-Risk Endometrial Cancer With PET/CT and Sentinel Lymph Node Mapping 221
Helmet CPAP to treat hypoxic pneumonia outside the ICU: an observational study during the COVID-19 outbreak 209
Histologic and metabolic assessment in a cohort of patients with genital prolapse: Preoperative stage and recurrence investigations 204
18F-FDG PET/CT can predict nodal metastases but not recurrence in early stage uterine cervical cancer 200
Risk of complications in patients with conservatively managed ovarian tumours (IOTA5): a 2-year interim analysis of a multicentre, prospective, cohort study 199
Iliococcygeus fixation or abdominal sacral colpopexy for the treatment of vaginal vault prolapse: a retrospective cohort study 198
Long-term results of fertility-sparing treatment compared with standard radical surgery for early-stage epithelial ovarian cancer 196
Characteristics of patients with cervical cancer during pregnancy: A multicenter matched cohort study. An initiative from the International Network on Cancer, Infertility and Pregnancy 195
Early-stage clear cell ovarian cancer compared to high-grade histological subtypes: An outcome exploratory analysis in two oncology centers 194
Better anatomical and cosmetic results using tunneled lotus petal flap for plastic reconstruction after demolitive surgery for vulvar malignancy 191
Clinical and ultrasound characteristics of the microcystic elongated and fragmented (MELF) pattern in endometrial cancer according to the International Endometrial Tumor Analysis (IETA) criteria 190
Heterotypic CAF-tumor spheroids promote early peritoneal metastatis of ovarian cancer 185
A prognostic regulatory pathway in stage I epithelial ovarian cancer: New hints for the poor prognosis assessment 183
Preoperative 18F-FDG PET/CT in the management of advanced epithelial ovarian cancer 182
Preoperative staging of cervical cancer: is 18-FDG-PET/CT really effective in patients with early stage disease? 181
GestaTIonal TrophoblAstic NeoplasIa Ultrasound assessMent: TITANIUM study 181
Tailoring systematic lymphadenectomy in high-risk clinical early stage endometrial cancer: the role of 18F-FDG PET/CT 180
Two ultrastaging protocols for the detection of lymph node metastases in early-stage cervical and endometrial cancers 176
Adjuvant sequential chemo and radiotherapy improves the oncological outcome in high risk endometrial cancer 175
Detection of TP53 Clonal Variants in Papanicolaou Test Samples Collected up to 6 Years Prior to High-Grade Serous Epithelial Ovarian Cancer Diagnosis 174
Child development at 6 years after maternal cancer diagnosis and treatment during pregnancy 174
The contribution of a collagen-fibrin patch (Tachosil) to prevent the postoperative lymphatic complications after groin lymphadenectomy: A double institution observational study 172
LncRNAs as novel indicators of patients' prognosis in stage i epithelial ovarian cancer: A retrospective and multicentric study 172
Machine learning risk prediction of mortality for patients undergoing surgery with perioperative SARS-CoV-2: The COVIDSurg mortality score 171
Detection of nodal metastases by 18F-FDG PET/CT in apparent early stage ovarian cancer: a prospective study 169
Real-Time Single-Walled Carbon Nanotube-Based Fluorescence Imaging Improves Survival after Debulking Surgery in an Ovarian Cancer Model 169
Ovarian carcinoma tumor-initiating cells have a mesenchymal phenotype 165
OC13. 02: Reproducibility of IETA terms in describing endometrial pathology 165
Oophorectomy and risk of contralateral breast cancer among BRCA1 and BRCA2 mutation carriers 165
Randomized phase III clinical trial evaluating weekly cisplatin for advanced epithelial ovarian cancer 163
Imaging in gynecological disease (16): clinical and ultrasound characteristics of serous cystadenofibromas in adnexa 163
Treatment of simple and complex endometrial non-atypical hyperplasia with natural progesterone: response rate to different doses 162
Delivery delay with neoadjuvant chemotherapy for cervical cancer patients during pregnancy: A series of nine cases and literature review 161
Managing Ovarian tumors during pregnancy 161
PRL-3 phosphatase is implicated in ovarian cancer growth 159
Conservative management of early-stage epithelial ovarian cancer: results of a large retrospective series 159
Systematic lymphadenectomy in ovarian cancer at second-look surgery: a randomised clinical trial 159
601: Cisplatin response in a panel of patient-derived ovarian carcinoma xenografts: roles of epithelial mesenchymal transition and DNA repair 159
Clinical utility of risk modelsto refer patients with adnexal masses to specialized oncology care: Multicenter external validation using decision curve analysis 157
Simple ultrasound rules to distinguish between benign and malignant adnexal masses before surgery: prospective validation by IOTA group 156
Resistance to platinum-based chemotherapy is associated with epithelial to mesenchymal transition in epithelial ovarian cancer 155
Imaging in gynecological disease (15): clinical and ultrasound characteristics of uterine sarcoma 155
Association between miR-200c and the survival of patients with stage I epithelial ovarian cancer: a retrospective study of two independent tumour tissue collections 154
The use of TachoSil for the prevention of postoperative complications after groin dissection in cases of gynecologic malignancy 154
Regional and temporal heterogeneity of epithelial ovarian cancer tumor biopsies: implications for therapeutic strategies 154
The Zinc Finger Gene ZIC2 Has Features of an Oncogene and Its Overexpression Correlates Strongly with the Clinical Course of Epithelial Ovarian Cancer 151
External validation of diagnostic models to estimate the risk of malignancy in adnexal masses 148
Ovarian Carcinoma Xenografts–Drug Response and Molecular Characterization 148
The role of pelvic and aortic lymphadenectomy at second look surgery in apparent early stage ovarian cancer after inadequate surgical staging followed by adjuvant chemotherapy 147
Ascites interferes with the activity of lurbinectedin and trabectedin: Potential role of their binding to alpha 1-acid glycoprotein 147
Overcoming platinum-acquired resistance in ovarian cancer patient-derived xenografts 146
Patient-derived ovarian tumor xenografts recapitulate human clinicopathology and genetic alterations 145
Delaying surgery for patients with a previous SARS-CoV-2 infection 142
Validation of ultrasound strategies to assess tumor extension and to predict high-risk endometrial cancer in women from the prospective IETA (International Endometrial Tumour Analysis) 4 cohort 140
Long-term follow-up of patients with an isolated ovarian recurrence after conservative treatment of epithelial ovarian cancer: review of the results of an international multicenter study comprising 545 patients 139
Synchronous early-stage endometrial and ovarian cancer 135
Melanoma during pregnancy: A report of 60 pregnancies complicated by melanoma 134
Is there any therapeutic role of pelvic and para-aortic lymphadenectomy in apparent early stage epithelial ovarian cancer? 134
Maximum standardized uptake value (SUVmax) as prognostic factor for surgical cytoreduction and response to adjuvant chemotherapy in women submitted to 18F-FDG PET/CT for staging of advanced epithelial ovarian cancer (aEOC) 132
Adnexal masses difficult to classify as benign or malignant using subjective assessment of gray-scale and Doppler ultrasound findings: logistic regression models do not help 131
Ultrasound characteristics of endometrial cancer as defined by the International Endometrial Tumor Analysis (IETA) consensus nomenclature - A prospective multicenter study 131
925pmatched cohort study on patients with cervical cancer diagnosed during pregnancy 130
Profiling cancer gene mutations in longitudinal epithelial ovarian cancer biopsies by targeted next-generation sequencing: a retrospective study 130
microRNA-181a has a critical role in ovarian cancer progression through the regulation of the epithelial-mesenchymal transition 130
Oncological management and obstetric and neonatal outcomes for women diagnosed with cancer during pregnancy: a 20-year international cohort study of 1170 patients 130
Gynecologic cancers in pregnancy: Guidelines based on a third international consensus meeting 126
Breast cancer risk after age 60 among BRCA1 and BRCA2 mutation carriers 126
Pentraxin 3 in plasma and vaginal fluid in women with preterm delivery 124
Prognosis of patients with cervical cancer diagnosed during pregnancy 124
Platinum sensitivity and DNA repair in a recently established panel of patient-derived ovarian carcinoma xenografts 124
Ovarian cancer prediction in adnexal masses using ultrasound based logistic regression models: a temporal and external validation study by the IOTA group 123
Patient-derived ovarian cancer xenografts re-growing after a cisplatinum treatment are less responsive to a second drug re-challenge: a new experimental setting to study response to therapy 123
MiRNA landscape in stage I epithelial ovarian cancer defines the histotype specificities 122
Embryo transfer following in vitro maturation and cryopreservation of oocytes recovered from antral follicles during conservative surgery for ovarian cancer 121
The role of transvaginal ultrasound in the workup of invasive molar disease 121
A phase II randomised clinical trial comparing cisplatin, paclitaxel and ifosfamide with cisplatin, paclitaxel and epirubicin in newly diagnosed advanced epithelial ovarian cancer: long-term survival analysis 120
DNA-damage response gene polymorphisms and therapeutic outcomes in ovarian cancer 120
Harmonic scalpel versus conventional electrosurgery in the treatment of vulvar cancer 119
A phase II clinical trial of topotecan and carboplatin in patients with newly diagnosed advanced epithelial ovarian cancer 119
Prognostic factors for recurrence and survival among patients with invasive vulvar Paget disease included in the VULCAN study 119
Tubal histopathological abnormalities in BRCA1/2 mutation carriers undergoing prophylactic salpingo-oophorectomy: a case-control study 119
Assessment of nodal status by 18F-FDG PET/CT in early stage ovarian cancer 118
The impact of DNA damage response gene polymorphisms on therapeutic outcomes in late stage ovarian cancer 118
Ultrasound-based risk model for preoperative prediction of lymph-node metastases in women with endometrial cancer: model-development study 118
A phase II, randomized trial of neo-adjuvant chemotherapy comparing a three-drug combination of paclitaxel, ifosfamide, and cisplatin (TIP) versus paclitaxel and cisplatin (TP) followed by radical surgery in patients with locally advanced squamous cell cervical carcinoma: the Snap-02 Italian Collaborative Study 118
Phase I study of SU5416, a small molecule inhibitor of the vascular endothelial growth factor receptor (VEGFR) in refractory pediatric central nervous system tumors 117
Platinum, anthracycline, and alkylating agent-based chemotherapy for ovarian carcinosarcoma 117
Regulator of G-protein signaling 5 (RGS5) protein: a novel marker of cancer vasculature elicited and sustained by the tumor's proangiogenic microenvironment 116
Gastric cancer during pregnancy: A report on 13 cases and review of the literature with focus on chemotherapy during pregnancy 116
Totale 17.004
Categoria #
all - tutte 101.401
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 101.401


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.977 0 0 316 445 438 582 656 362 507 256 280 135
2020/20214.136 224 177 332 423 326 355 427 496 374 424 226 352
2021/20222.629 205 226 211 250 149 252 121 147 139 254 218 457
2022/20234.327 475 1.202 357 329 253 688 118 247 326 44 162 126
2023/20244.313 127 142 238 269 503 948 776 184 352 133 123 518
2024/20252.066 583 1.228 255 0 0 0 0 0 0 0 0 0
Totale 27.914